BIOCYTOGEN
3.1.2023 15:24:36 CET | Business Wire | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", SEHK : 02315) a clinical-stage biotechnology company with a focus on the antibody discovery and development based on its proprietary RenMiceTM Platforms, and Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”, SEHK: 3692), a leading innovation-driven pharmaceutical company with a focus on the treatment of major diseases including oncology, infectious diseases, CNS disorders, metabolic diseases and autoimmune diseases, today announced an antibody collaboration, assignment and exclusive license agreement. Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules against the designated target for the development, manufacturing and commercialization globally. Under the agreement, Biocytogen will receive an upfront payment and will be eligible to receive development and commercial milestones of up to tens of millions of Chinese yuan, as well as single-digit tiered royalties on net sales.
“We are very excited to partner with Hansoh Pharma, one of the largest pharmaceutical companies in China. The licensed antibodies were selected from Biocytogen’s Project Integrum programs and generated from our proprietary fully human antibody RenMiceTM target-knockout mice. The antibodies possess highest possible diversity to improve the success rate of antibody discovery,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “Thanks to Hansoh Pharma’s recognition of our RenMiceTM platforms and Project Integrum. We believe Hansoh Pharma’s strong R&D, manufacturing and commercialization capabilities will accelerate the development of RenMiceTM-derived antibody molecules and bring the benefits to patients worldwide.”
About Project Integrum
Project Integrum is a large-scale antibody drug development project for 1000+ potential drug targets using RenMiceTM (RenMabTM, RenLite® and RenNano®) target knockout mice. Different from the traditional mechanism of action (MOA)-based drug development strategy, Project Integrum uses large-scale in vivo drug efficacy screening methods to discover innovative drugs with excellent safety and efficacy. So far, we have completed making RenMiceTM KO for 1000+ targets. In addition, we have developed a large variety of preclinical antibody assets including 10 fully human bispecific antibodies, 20+ bispecific ADCs, 10+ TCR-mimic antibodies, 30+ monoclonal antibodies against novel targets, and 600+ antibody hits. Antibody molecules generated by Project Integrum have high specificity, high affinity and good druggability, which have attracted many top biopharmaceutical companies to obtain a license or reach a drug co-development agreement with us, including Merck KGaA, ADC Therapeutics, Remgen, NJCTTQ, etc.
About Biocytogen
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Using its proprietary RenMabTM/RenLite®/RenNano® mice platforms for fully human monoclonal, bispecific/multispecific antibody and nanobody development, Biocytogen has integrated its in vivo drug efficacy screening platforms and strong clinical development expertise to streamline the entire drug development process. Biocytogen is undertaking a large-scale project to develop first-in-class and/or best-in-class antibody drugs for more than 1000 targets, known as Project Integrum. This project has resulted in 28 drug co-development agreements and 16 RenMiceTM licensing agreements with companies around the world, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen's pipeline includes 12 core products, among which two products are in phase II multi-regional clinical trials and two products are in phase I. Headquartered in Beijing, Biocytogen has branches in Haimen Jiangsu, Shanghai, Boston, USA and Heidelberg, Germany. For more information, please visit http://en.biocytogen.com.cn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230103005498/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OPEX® Corporation to Exhibit Advanced Warehouse Automation Solutions at LogiMAT 20264.3.2026 09:00:00 CET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, will exhibit its latest advancements in warehouse automation at LogiMAT 2026. The world’s largest trade show for intralogistics solutions and process management, LogiMAT will be held March 24 through 26 at the Stuttgart Trade Fair Center in Germany. “Our team looks forward to being onsite at LogiMAT and showcasing several of our leading warehouse automation solutions,” said Alex Stevens, President, Warehouse Automation, OPEX. “We’re proud to deliver cutting-edge systems that help our clients transform how they conduct business, and we appreciate the vast opportunity LogiMAT provides to share our offerings and expertise with event attendees.” At LogiMAT Hall 5 ‒ Stand B25, OPEX will demonstrate Sure Sort® X with Xtract, its award-winning, automated pack-out and order takeaway system. The OPEX Booth will also feature a static display of the company’
Twilio and KPN Partnership Unlocks the Next Generation of Secure Business Messaging in the Netherlands, Powered by Google4.3.2026 09:00:00 CET | Press release
Milestone marks nationwide operator support for RCS Business Messaging, opening a scalable new market for brands Twilio (NYSE: TWLO), the customer engagement platform that drives real-time, personalised experiences for today’s leading brands, today announced at Mobile World Congress a partnership with KPN Netherlands (KPN) to enable nationwide Rich Communication Services (RCS) Business Messaging across all major mobile operators in the Netherlands, powered by Twilio and Google. RCS Business Messaging combines the simplicity and reach of sms with rich, interactive features such as verified sender identity, images, carousels and action buttons. This allows businesses to communicate in a more engaging, secure and measurable way, strengthening customer trust and improving the overall experience. Enabling nationwide RCS in the Netherlands With nation-wide coverage, KPN plays a central role in the country’s digital infrastructure. By joining the growing RCS ecosystem, this marks a defining m
SES Brings Satellite Connectivity to Refugees in Chad4.3.2026 08:50:00 CET | Press release
First Medium-Earth Orbit (MEO) deployment of the emergency.lu platform for refugees and their host communities’ use provides dependable broadband for humanitarian responders, classrooms and community connectivity centers SES, a space solutions company, is expanding humanitarian connectivity at the Farchana refugee settlement in Chad in cooperation with emergency.lu, the public-private partnership led by Luxembourg’s Ministry of Foreign and European Affairs, Defence, Development Cooperation and Foreign Trade and the UN Refugee Agency. In the framework of the Connectivity for Refugees initiative, the deployment uses SES’ O3b mPOWER satellite network to provide dependable, high-speed internet for humanitarian teams and essential services for refugees. This is the first emergency.lu deployment using O3b mPOWER satellites in Medium Earth Orbit (MEO), an expansion beyond the program’s previous use of geostationary (GEO) satellites for rapid disaster-response missions. It also marks a new app
Travel Smarter: Thales and Airalo Unlock a Seamless Global eSIM Experience4.3.2026 08:00:00 CET | Press release
Powered by Thales’ secure technology in eSIM connectivity management, this new solution ensures fast connection to local networks worldwide, delivering a smoother, more intuitive eSIM experience. For travellers, this means a simple eSIM installation for a seamless experience across 200+ destinations, making global connectivity as effortless and accessible as booking a flight or hotel. International travellers have increasingly relied on travel eSIMs to avoid high roaming fees, the hassle of searching for a local SIM card or relying on Wi-Fi hotspots. While this has improved connectivity access for millions, the process in the travel space remains cumbersome, still requiring manual configuration for each trip. By integrating Thales’ eSIM capabilities into its global platform, Airalo, the world’s largest travel eSIM platform, is further enhancing its technical architecture to provide its over 20 million users with a smoother travel experience. This press release features multimedia. View
Kao’s Laurier Launches New Brand Communication Initiative across Asia: Strengthening Global Integration as a Core Brand in Kao’s Asian Business4.3.2026 03:10:00 CET | Press release
Starting on International Women’s Day, March 8, Kao Corporation (TOKYO:4452) will launch new brand communication campaign in nine Asian countries and regions for its feminine sanitary product brand, Laurier, which is the core of its Asian business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303996141/en/ Laurier Campaign Key Visual Laurier aims to help create more supportive and understanding environments around menstruation, so that women can feel more at ease, both physically and emotionally, under the key message “Comfort, Made Together,” which will be implemented simultaneously across Asia. Kao aims to further develop Laurier as a global brand. Laurier, one of the core brands supporting Kao’s consumer care business in Asia, has been promoting globally integrated operations since 2023. Across all nine Asian countries and regions including Japan, Laurier has been working to unify product specifications and consolida
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom